USPTO serial 79167813
HISTIDE RECODING THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 4975359Status 404
- Filing date
- Status date
- Registration date
- Jun 14, 2016
- Examiner
- PARKS, KIMBERLY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HISTIDE RECODING THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CH-8834 Schindellegi, CH
CH-8834 Schindellegi, CH
CH-8834 Schindellegi, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline M. Lesser
Jacqueline M. Lesser Baker & Hostetler LLP2929 Arch StreetCira Centre, 12th FloorPhiladelphia, PA 19104-2891Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for scientific use; chemical products for biotechnological product development; proteins in raw material form for scientific use; chemical products for the purification of proteins for in-vitro use; synthetic peptides for the manufacture of cosmetics; stem cells other than for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 003 | Cosmetics; cosmetic products for skin appearance care; cosmetic preparations for skin regeneration; non-medicated anti-aging skin care preparations; gels, lotions, non-medicated serums, creams and non-medicated general purpose ointments for cosmetic use; cosmetic preparations for hair restoration; hair lotions | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; stem cells for medical use; surgical implants comprising living tissues; surgical dressings in the form of cloths; surgical implants comprising living tissue grown from stem cells; synthesized peptides and polynucleotides (DNAs, RNAs) for pharmaceutical use for the treatment of tissue, whether relating to human or animal tissue, bone diseases, cartilaginous diseases, vascular diseases, neuronal degeneration, degeneration of tendons and ligaments, retinal degeneration, renal degeneration, degeneration of soft tissue, diseases with abnormal cell proliferation; nucleotide and amino acid preparations for medical use; biological tissue cultures for medical use | SECTION 71 - CANCELLED | — |
| 010 | Surgical apparatus and instruments; prostheses, namely, orthopedic prostheses, artificial joints, jaw or facial prostheses, tendon and ligament prostheses, bone prostheses, artificial bone screws, dental prostheses, vascular prostheses, heart pacemakers, artificial heart valves, breast prostheses, penile prostheses; artificial implants, namely, artificial orthopedic implants, joints, jaw or facial implants, tendon and ligament implants, skin implants, bone implants, dental implants, vascular implants, breast implants, penile implants, nerve growth implants, intraocular implants; bone substitutes for surgical use; injectors for medical use, namely, medical fluid injectors; trocars | SECTION 71 - CANCELLED | — |
| 042 | Technical consultancy in the field of scientific and industrial research; research and development of new products for others; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development in the field of cosmetics; biological research services; chemical research services; scientific research services in the field of amino acids, proteins and cells; scientific laboratory services; chemistry services, namely, chemistry consultation; conducting clinical trials for others; engineering services, namely, technical project studies; engineering; chemical analysis; engineering surveying | SECTION 71 - CANCELLED | — |
| 045 | Intellectual property licensing; on-line social networking services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Histide AG
- Other trademarks owned by Histide AG
- Other trademarks owned by Histide AG
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named HISTIDE RECODING THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Oct 10, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 9, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 16, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 16, 2023 | INPC | INVALIDATION PROCESSED | — |
| Aug 30, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 30, 2022 | C71T | CANCELLED SECTION 71 | — |
| Jun 14, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 13, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 16, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 16, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 14, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 14, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 29, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 9, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 9, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 25, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 18, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 20, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 19, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jan 5, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 27, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 24, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 6, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 6, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 3, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 2, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 27, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 27, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |